semaglutide replacement AOD 9604 vs. Patients Taking Semaglutide See Benefit
Description
Vieira AT, Galvao I, Macia LM, et al
Sleiman M.D
[DOI] [PubMed] [Google Scholar] 213.Chapli S, Bain S
)
Cardiovascular outcomes have been studied for several GLP-1 receptor agonists
The 48-week randomised controlled trial enrolled adults with a BMI 27 kg/m and evaluated five dose cohorts versus placebo
